- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: S-1-CCRT
Total 16713 results
-
Cancer Institute and Hospital, Chinese Academy...CompletedGastrointestinal Neoplasms | Gastric CancerChina
-
LanZhou UniversityUnknown
-
Chinese PLA General HospitalCure&Sure Biotech Co., LTDUnknownGastric CarcinomaChina
-
Abbott Medical DevicesTerminatedHeart FailureUnited States
-
University of ParmaCompletedDietary ModificationItaly
-
Japan Clinical Cancer Research OrganizationKorean Cancer Study GroupCompleted
-
Changzhou Cancer Hospital of Soochow UniversityCompletedNon-small Cell Lung CancerChina
-
Beijing Tiantan HospitalCompletedElectroencephalographyChina
-
Sun Yat-sen UniversityCompletedEsophageal Squamous Cell CarcinomaChina
-
Taiho Oncology, Inc.Quintiles, Inc.; United BioSource, LLCCompletedAdvanced Non-Small Cell Lung Cancer
-
Zhejiang Cancer HospitalCompletedEsophageal Cancer | ChemoradiationChina
-
Zhu XuUnknownHepatocellular CarcinomaChina
-
National Cancer Center, KoreaJeil Pharmaceutical Co., Ltd.UnknownAdvanced Non-Small Cell Lung CancerKorea, Republic of
-
Fudan UniversityUnknownCarcinoma, PancreaticChina
-
Hebei Medical University Fourth HospitalUnknownRefractory or Metastatic Esophageal Squamous Cell CarcinomaChina
-
Min-Hee RyuCompletedGastric CancerKorea, Republic of
-
Samsung Medical CenterCompletedSmall Cell Lung CancerKorea, Republic of
-
Eastern Network of Cancer Immunological Therapy...Terminated
-
Taiho Oncology, Inc.CompletedAdvanced or Metastatic Non-small Cell Lung CancerUnited States, France, Poland, Spain, Italy, Japan
-
Taiho Oncology, Inc.CompletedAdvanced Solid TumorsFrance, Belgium, Italy, Switzerland
-
Peking UniversityTaiho Pharmaceutical Co., Ltd.Unknown
-
Soonchunhyang University HospitalUnknownGastric Cancer | Elderly | Oxaliplatin | S-1 | First-Line
-
Kazuhiko YoshimatsuHuman Genome Center, Institute of Medical Science, University of TokyoCompletedColorectal CancerJapan
-
Fudan UniversityRecruiting
-
Universidad de La FronteraRecruitingPeriapical Diseases | Endodontic TreatmentChile
-
Cancer Institute and Hospital, Chinese Academy...Sanofi; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownCarcinoma, HepatocellularChina
-
Asan Medical CenterNational Cancer Center, Korea; Chonbuk National University Hospital; Samsung... and other collaboratorsCompletedAdvanced Gastric CancerKorea, Republic of
-
AIPING ZHOURecruiting
-
Japan Clinical Cancer Research OrganizationTaiho Pharmaceutical Co., Ltd.Unknown
-
Taiho Oncology, Inc.Quintiles, Inc.CompletedSecondary Malignant Neoplasm of Pancreas
-
Peking University Cancer Hospital & InstituteRecruitingGastric AdenocarcinomaChina
-
Ruijin HospitalRecruitingStage IIIC Gastric CancerChina
-
Taiho Oncology, Inc.Completed
-
National Cancer Center, KoreaUnknownStomach NeoplasmsKorea, Republic of
-
Samsung Medical CenterActive, not recruitingCervix Cancer | Radiotherapy, Adjuvant | Radiotherapy, Intensity-Modulated | Hypofractionated Dose | Chemotherapy, ConcurrentKorea, Republic of
-
Taiho Oncology, Inc.Completed
-
First People's Hospital of HangzhouCompletedCholangiocarcinomaChina
-
Zhejiang Cancer HospitalUnknown
-
Taiho Oncology, Inc.Completed
-
National Taiwan University HospitalUnknownColorectal CancerTaiwan
-
Samsung Medical CenterNational Cancer Center, Korea; Asan Medical Center; Chonnam National University... and other collaboratorsCompletedColorectal CancerKorea, Republic of
-
Cancer Institute and Hospital, Chinese Academy...CompletedStomach Neoplasms | Chemotherapy | Neoadjuvant Therapy | ChemoradiotherapyChina
-
The Affiliated Hospital of the Chinese Academy...UnknownPancreatic CancerChina
-
Biotronik SE & Co. KGCompletedSafety of MR (Magnetic Resonance) Conditional CRT-pacemakers and ICDsFrance, Germany, Hungary, Canada, Australia, Austria, Czech Republic, Switzerland
-
Tianjin Medical University Cancer Institute and...RecruitingGastric Cancer | Perioperative | SintilimabChina
-
Capital Medical UniversityDuke University; Geneplus-Beijing Co. Ltd.Completed
-
Samsung Medical CenterTerminatedPhase I: To Determine the Maximum Tolerated Dose (MTD) | Phase II: To Assess the Pathologic CR Rate and Feasibility Following Neoadjuvant Chemoradiation Therapy With S1/OxaliplatinKorea, Republic of
-
Jing Jin, M.D.Beijing Hope RunRecruitingGastric Cancer | Neoadjuvant TherapyChina
-
Quantum Genomics SACompleted